Tumor-associated a2 vacuolar ATPase acts as a key mediator of cancer-related inflammation by inducing pro-tumorigenic properties in monocytes

Journal of Immunology

Volumn 186, Issue 3, 2011, Pages 1781-1789

  Kwong, Christina ^a   Gilman Sachs, Alice ^a   Beaman, Kenneth ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A2 ISOFORM VACUOLAR ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 3; INTERLEUKIN 33; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; POTASSIUM ION; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; CELL VIABILITY; CHORIOCARCINOMA; CYTOKINE RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; KERATINOCYTE; MONOCYTE; OVARY ADENOCARCINOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN SECRETION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; UPREGULATION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; CYTOPLASMIC VESICLES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; ISOENZYMES; MONOCYTES; NEOPLASM PROTEINS; NEOPLASMS; PEPTIDES; PROTEIN PRECURSORS; SIGNAL TRANSDUCTION; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 79251549474     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002998     Document Type: Article

References (62)

1. Colotta, F., P. Allavena, A. Sica, C. Garlanda, and A. Mantovani. 2009. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-1081.
2. Mantovani, A., P. Romero, A. K. Palucka, and F. M. Marincola. 2008. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet 371: 771-783.
3. Balkwill, F., and A. Mantovani. 2001. Inflammation and cancer: back to Virchow? Lancet 357: 539-545.
4. +-ATPase in cancer biology. Cell Biochem. Biophys. 40: 185-206.
5. +-ATPases are functionally expressed in plasma membranes of human tumor cells. Am. J. Physiol. 265: C1015-C1029.
6. Rofstad, E. K., B. Mathiesen, K. Kindem, and K. Galappathi. 2006. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res. 66: 6699-6707.
7. Kubota, S., and Y. Seyama. 2000. Overexpression of vacuolar ATPase 16-kDa subunit in 10T1/2 fibroblasts enhances invasion with concomitant induction of matrix metalloproteinase-2. Biochem. Biophys. Res. Commun. 278: 390-394.
8. +-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am. J. Physiol. Cell Physiol. 286: C1443-C1452.
9. Ntrivalas, E., A. Gilman-Sachs, J. Kwak-Kim, and K. Beaman. 2007. The N-terminus domain of the a2 isoform of vacuolar ATPase can regulate interleukin-1β production from mononuclear cells in co-culture with JEG-3 choriocarcinoma cells. Am. J. Reprod. Immunol. 57: 201-209.
10. Ntrivalas, E., R. Derks, A. Gilman-Sachs, J. Kwak-Kim, R. Levine, and K. Beaman. 2007. Novel role for the N-terminus domain of the a2 isoform of vacuolar ATPase in interleukin-1β production. Hum. Immunol. 68: 469-477.
11. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35.
12. Mosser, D. M. 2003. The many faces of macrophage activation. J. Leukoc. Biol. 73: 209-212.
13. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549-555. (Pubitemid 35223554)
14. Lewis, C. E., and J. W. Pollard. 2006. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66: 605-612.
15. Schetter, A. J., N. H. Heegaard, and C. C. Harris. 2010. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31: 37-49.
16. Allavena, P., A. Sica, C. Garlanda, and A. Mantovani. 2008. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol. Rev. 222: 155-161.
17. Derks, R., and K. Beaman. 2004. Regeneration and tolerance factor modulates the effect of adenosine triphosphate-induced interleukin 1β secretion in human macrophages. Hum. Immunol. 65: 676-682.
18. Caby, M. P., D. Lankar, C. Vincendeau-Scherrer, G. Raposo, and C. Bonnerot. 2005. Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 17: 879-887.
19. Boukamp, P., R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106: 761-771.
20. Lattuada, D., S. Mangioni, P. Viganò, E. I. Ntrivalas, M. Rossi, F. Palotti, S. Carinelli, K. D. Beaman, and A. M. Di Blasio. 2004. The placental immunomodulatory cytokine regeneration and tolerance factor is also expressed by both human cycling and early pregnant endometrium. Am. J. Reprod. Immunol. 52: 224-231.
21. Lee, G. W., J. S. Boomer, A. Gilman-Sachs, A. Chedid, L. Gudelj, D. Rukavina, and K. D. Beaman. 2001. Regeneration and tolerance factor of the human placenta induces IL-10 production. Eur. J. Immunol. 31: 687-691.
22. Lakkaraju, A., and E. Rodriguez-Boulan. 2008. Itinerant exosomes: emerging roles in cell and tissue polarity. Trends Cell Biol. 18: 199-209.
23. Cocucci, E., G. Racchetti, and J. Meldolesi. 2009. Shedding microvesicles: artefacts no more. Trends Cell Biol. 19: 43-51.
24. Bianco, F., E. Pravettoni, A. Colombo, U. Schenk, T. Möller, M. Matteoli, and C. Verderio. 2005. Astrocyte-derived ATP induces vesicle shedding and IL-1β release from microglia. J. Immunol. 174: 7268-7277. (Pubitemid 40705696)
25. Al-Nedawi, K., B. Meehan, and J. Rak. 2009. Microvesicles: messengers and mediators of tumor progression. Cell Cycle 8: 2014-2018.
26. Schorey, J. S., and S. Bhatnagar. 2008. Exosome function: from tumor immunology to pathogen biology. Traffic 9: 871-881.
27. Chan, G., E. R. Bivins-Smith, M. S. Smith, and A. D. Yurochko. 2008. Transcriptome analysis of NF-κB- and phosphatidylinositol 3-kinase-regulated genes in human cytomegalovirus-infected monocytes. J. Virol. 82: 1040-1046.
28. Sakurai, H., H. Chiba, H. Miyoshi, T. Sugita, and W. Toriumi. 1999. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274: 30353-30356.
29. Bonizzi, G., and M. Karin. 2004. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25: 280-288. (Pubitemid 38610351)
30. Netea, M. G., C. A. Nold-Petry, M. F. Nold, L. A. Joosten, B. Opitz, J. H. van der Meer, F. L. van de Veerdonk, G. Ferwerda, B. Heinhuis, I. Devesa, et al. 2009. Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages. Blood 113: 2324-2335.
31. Ferrari, D., P. Chiozzi, S. Falzoni, S. Hanau, and F. Di Virgilio. 1997. Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185: 579-582.
32. Pétrilli, V., S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp. 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14: 1583-1589. (Pubitemid 47278844)
33. Schroder, K., and J. Tschopp. 2010. The inflammasomes. Cell 140: 821-832.
34. Mantovani, A., A. Sica, P. Allavena, C. Garlanda, and M. Locati. 2009. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum. Immunol. 70: 325-330.
35. Martínez-Zaguilán, R., E. A. Seftor, R. E. Seftor, Y. W. Chu, R. J. Gillies, and M. J. Hendrix. 1996. Acidic pH enhances the invasive behavior of human melanoma cells. Clin. Exp. Metastasis 14: 176-186.
36. Coakley, R. J., C. Taggart, N. G. McElvaney, and S. J. O'Neill. 2002. Cytosolic pH and the inflammatory microenvironment modulate cell death in human neutrophils after phagocytosis. Blood 100: 3383-3391.
37. Hinoki, A., K. Yoshimura, K. Fujita, M. Akita, R. Ikeda, M. Nagashima, M. Nomura, and A. Satomi. 2006. Suppression of proinflammatory cytokine production in macrophages by lansoprazole. Pediatr. Surg. Int. 22: 915-923.
38. Huang, X., A. Masselli, S. M. Frisch, I. C. Hunton, Y. Jiang, and J. Y. Wang. 2007. Blockade of tumor necrosis factor-induced Bid cleavage by caspase-resistant Rb. J. Biol. Chem. 282: 29401-29413.
39. Hagemann, T., S. K. Biswas, T. Lawrence, A. Sica, and C. E. Lewis. 2009. Regulation of macrophage function in tumors: the multifaceted role of NF-κB. Blood 113: 3139-3146.
40. Cao, S., X. Zhang, J. P. Edwards, and D. M. Mosser. 2006. NF-κB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J. Biol. Chem. 281: 26041-26050.
41. Saccani, A., T. Schioppa, C. Porta, S. K. Biswas, M. Nebuloni, L. Vago, B. Bottazzi, M. P. Colombo, A. Mantovani, and A. Sica. 2006. p50 nuclear factor-κB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 66: 11432-11440.
42. Chomarat, P., J. Banchereau, J. Davoust, and A. K. Palucka. 2000. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1: 510-514.
43. Kapsenberg, M. L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3: 984-993.
44. + T cells resulting in a failure to lyse tumor cells. Blood 93: 1634-1642.
45. Menetrier-Caux, C., M. C. Thomachot, L. Alberti, G. Montmain, and J. Y. Blay. 2001. IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells. Cancer Res. 61: 3096-3104.
46. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686.
47. Fink, S. L., and B. T. Cookson. 2005. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73: 1907-1916.
48. Bergsbaken, T., S. L. Fink, and B. T. Cookson. 2009. Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7: 99-109.
49. Roy, D., S. Sarkar, and Q. Felty. 2006. Levels of IL-1β control stimulatory/inhibitory growth of cancer cells. Front. Biosci. 11: 889-898.
50. Vidal-Vanaclocha, F., G. Fantuzzi, L. Mendoza, A. M. Fuentes, M. J. Anasagasti, J. Martín, T. Carrascal, P. Walsh, L. L. Reznikov, S. H. Kim, et al. 2000. IL-18 regulates IL-1β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc. Natl. Acad. Sci. USA 97: 734-739.
51. Maeda, S., H. Kamata, J. L. Luo, H. Leffert, and M. Karin. 2005. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121: 977-990.
52. Elaraj, D. M., D. M. Weinreich, S. Varghese, M. Puhlmann, S. M. Hewitt, N. M. Carroll, E. D. Feldman, E. M. Turner, and H. R. Alexander. 2006. The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin. Cancer Res. 12: 1088-1096.
53. Sethi, G., B. Sung, and B. B. Aggarwal. 2008. TNF: a master switch for inflammation to cancer. Front. Biosci. 13: 5094-5107.
54. Mantovani, A., P. Allavena, A. Sica, and F. Balkwill. 2008. Cancer-related inflammation. Nature 454: 436-444.
55. Mocellin, S., and D. Nitti. 2008. TNF and cancer: the two sides of the coin. Front. Biosci. 13: 2774-2783.
56. Srikrishna, G., and H. H. Freeze. 2009. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 11: 615-628.
57. Gocheva, V., and J. A. Joyce. 2007. Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 6: 60-64.
58. Hinton, A., S. Bond, and M. Forgac. 2009. V-ATPase functions in normal and disease processes. Pflugers Arch. 457: 589-598.
59. Gatenby, R. A., and R. J. Gillies. 2004. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4: 891-899.
60. Liu, C., S. Yu, K. Zinn, J. Wang, L. Zhang, Y. Jia, J. C. Kappes, S. Barnes, R. P. Kimberly, W. E. Grizzle, and H. G. Zhang. 2006. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J. Immunol. 176: 1375-1385.
61. Théry, C., M. Ostrowski, and E. Segura. 2009. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9: 581-593.
62. +-ATPases as a new strategy against cancer. Cancer Res. 67: 10627-10630.